Long-term outcomes of mitral valve replacement in dialysis patients: evidence from a nationwide database

被引:0
|
作者
Yang, Kelvin J. [1 ]
Fu, Hsun-Yi [2 ]
Chang, Chia-Jui [3 ,4 ]
Wang, Ting-Chuan [5 ]
Wang, Chih-Hsien [1 ]
Chou, Nai-Kuan [1 ]
Wu, I-Hui [1 ]
Hsu, Ron-Bin [1 ]
Huang, Shu-Chien [1 ]
Yu, Hsi-Yu [1 ]
Chen, Yih-Sharng [1 ]
Chi, Nai-Hsin [1 ,6 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Hsin Chu Branch, Hsinchu, Taiwan
[3] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Canc Ctr, Dept Pharm, Taipei, Taiwan
[5] Natl Taiwan Univ, Hlth Data Res Ctr, Taipei, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Surg, 8 Chung Shan S Rd, Taipei, Taiwan
关键词
end-stage renal disease; hemodialysis; mitral valve; prosthetic valve; valve replacement; STAGE RENAL-DISEASE; AMERICAN-HEART-ASSOCIATION; TASK-FORCE; MANAGEMENT; GUIDELINES; SURVIVAL; KIDNEY;
D O I
10.1097/JS9.0000000000000684
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: To compare the late outcomes between mechanical and bioprostheses after isolated mitral valve replacement (MVR) in dialysis-dependent patients. Methods: A nationwide propensity-matched retrospective cohort study was conducted involving dialysis patients who underwent primary mitral replacement between 2001 and 2018. Ten-year postoperative outcomes were compared between mitral bioprosthesis and mechanical prosthesis using the Cox proportional hazard model and restricted mean survival time (RMST). Results: The all-cause mortality was 20.8 and 13.0 events per 100 person-years, with a 10-year RMST of 7.40 and 7.31 years for bioprosthesis and mechanical prosthesis, respectively. Major bleeding was the most common adverse event for both bioprosthesis and mechanical prosthesis, with an incidence rate of 19.5 and 19.1 events per 100 person-years, respectively. The incidence of valve reoperation was higher among those who received bioprosthesis (0.55 events per 100 person-years). After 1:1 matching, the all-cause mortality was 15.45 and 14.54 events per 100 person-years for bioprosthesis and mechanical prosthesis, respectively. The RMST at 10 years was comparable between the two groups after matching (5.10 years for bioprosthesis vs. 4.59 years for mechanical prosthesis), with an RMST difference of -0.03. Further, no difference was observed in the incidence of major adverse valve-related events between bioprosthesis and mechanical valves. However, bioprosthesis was associated with a higher incidence of mitral valve reoperation among all major adverse events (RMST difference -0.24 years, 95% CI -0.48 to -0.01, P=0.047). Conclusions: This study found no association between valve selection and long-term survival outcomes in dialysis patients after MVR. However, bioprosthetic valves may be associated with a slightly higher incidence of reoperation, while other valve-related adverse events, including major bleeding and stroke, were comparable between the two types of prostheses.
引用
收藏
页码:3778 / 3787
页数:10
相关论文
共 50 条
  • [21] Long-Term Outcomes of Bioprosthetic and Mechanical Valve Replacement for Patients Aged between 50 and 70 Years
    Zhao, Wei
    Chen, Zhongli
    Chen, Sipeng
    Du, Junzhe
    Zhang, Heng
    Zhao, Yan
    He, Li
    Feng, Wei
    Sun, Hansong
    Zheng, Zhe
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (09)
  • [22] Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement
    Kim, Joon Bum
    Kim, Hee Jung
    Moon, Duk Hwan
    Jung, Sung Ho
    Choo, Suk Jung
    Chung, Cheol Hyun
    Song, Hyun
    Lee, Jae Won
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 37 (05) : 1039 - 1046
  • [23] Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgery
    Cetinkaya, Ayse
    Ganchewa, Natalia
    Hein, Stefan
    Bramlage, Karin
    Bramlage, Peter
    Schoenburg, Markus
    Richter, Manfred
    JOURNAL OF CARDIOTHORACIC SURGERY, 2020, 15 (01)
  • [24] Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgery
    Ayse Cetinkaya
    Natalia Ganchewa
    Stefan Hein
    Karin Bramlage
    Peter Bramlage
    Markus Schönburg
    Manfred Richter
    Journal of Cardiothoracic Surgery, 15
  • [25] Is it worth repairing rheumatic mitral valve disease in children? Long-term outcomes of an aggressive approach to rheumatic mitral valve repair compared to replacement in young patients
    Moorthy, Paneer Selvam Krishna
    Sivalingam, Sivakumar
    Dillon, Jeswant
    Kong, Pau Kiew
    Yakub, Mohd Azhari
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 28 (02) : 191 - 198
  • [26] Long-Term Outcomes of Mitral Valve Repair for Active Endocarditis
    Kanemitsu, Hideo
    Nakamura, Ken
    Fukunaga, Naoto
    Koyama, Tadaaki
    CIRCULATION JOURNAL, 2016, 80 (05) : 1148 - 1152
  • [27] Long-Term Outcomes of Mechanical Valve Replacement in Patients With Atrial Fibrillation Impact of the Maze Procedure
    Kim, Joon Bum
    Moon, Joon Suk
    Yun, Sung-Cheol
    Kim, Wan Kee
    Jung, Sung-Ho
    Choo, Suk Jung
    Song, Hyun
    Chung, Cheol Hyun
    Lee, Jae Won
    CIRCULATION, 2012, 125 (17) : 2071 - 2080
  • [28] Long-term outcomes of pulmonary valve replacement in patients with repaired tetralogy of Fallot
    Lee, Cheul
    Choi, Eun Seok
    Lee, Chang-Ha
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (02) : 246 - 252
  • [29] Long-term results of bioprosthetic mitral valve replacement the pericardial perspective
    Doenst, T
    Borger, MA
    David, TE
    JOURNAL OF CARDIOVASCULAR SURGERY, 2004, 45 (05) : 449 - 454
  • [30] Long-term left atrial thrombi after mitral valve replacement
    Chen, Jindong
    Wang, Hao
    Xie, Xiaoyi
    Dai, Huangdong
    Zhou, Mengmeng
    Zheng, Yue
    Zhao, Liang
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (01) : 129 - 135